Skip to Content
U.S. News & World Report 14 Consecutive Years
Home > Research & Science
The discoveries made in the laboratories at National Jewish Health have a profound impact on the understanding and treatment of human disease, with an emphasis on respiratory, immune and related diseases.
Browse our areas of research.
Institute for Advanced Biomedical ImagingThe Institute for Advanced Biomedical Imaging offers cutting-edge technology in combination with some of the best chest radiologists in the world to provide advanced diagnostics that are central to personalized medicine.
Potential Treatment for Idiopathic Pulmonary Fibrosis and Other Fibrotic ConditionsDavid Riches, PhD has found that blocking the association of PTPN13 to Fas induces fibroblasts cellular death. Since excessive accumulation of living fibroblasts in the lungs is characteristic of Idiopathic Pulmonary Fibrosis, this finding has therapeutic potential for the treatment of this disorder
Technology Transfer Office
We conduct clinical trials for patients with asthma, allergy, COPD, eczema, ILD, cystic fibrosis and more.
Search All Clinical Trials
Basic Science ResearchThe search for new medicines and therapies begins in the laboratory where scientists use a variety of model systems to understand how cells perform their normal function and how they interact and communicate with each other in normal and disease situations.
All Research Programs & Departments
Research Achievements
Looking for answers? Ask your medical librarian, your key to quality information for healthcare, education and scientific research. Learn more.
Search AllSearch for library resources.
Request an Appt.Refer a PatientPatient Information
1.877.CALL NJH (877.225.5654)
eNewsletters and More
Studying the Biology of BiofeedbackResearchers are delving into the biology of biofeedback to understand how it helps asthma patients and how it might help reduce medication use. Read more.
Sarcoidosis. PubMed
Exposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industry. PubMed
More publications.